Black Rock Inc. Inmune Bio, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 812,895 shares of INMB stock, worth $3.96 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
812,895
Previous 240,166
238.47%
Holding current value
$3.96 Million
Previous $2.82 Million
154.13%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding INMB
# of Institutions
70Shares Held
5.9MCall Options Held
243KPut Options Held
46.4K-
Praetorian Pr LLC Rincon, PR781KShares$3.8 Million1.64% of portfolio
-
Vanguard Group Inc Valley Forge, PA721KShares$3.51 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$2.9 Million45.87% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL369KShares$1.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA344KShares$1.68 Million0.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $87.4M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...